Effects of subchronic and chronic melatonin treatment on somatostatin binding and its effects on adenylyl cyclase activity in the rat frontoparietal cortex

Journal of Pineal Research

Volumn 33, Issue 4, 2002, Pages 189-197

  Izquierdo Claros, Rosa María ^a   Del Carmen Boyano Adánez, María ^a   Arilla Ferreiro, Eduardo ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Adenylyl cyclase; Frontoparietal cortex; G proteins; Melatonin; Rat; Somatostatin receptors

Indexed keywords

ADENYLATE CYCLASE; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; IODINE 125; MELATONIN; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; BRAIN MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVITY; HORMONE RECEPTOR INTERACTION; IMMUNOREACTIVITY; LOCOMOTION; NONHUMAN; RAT; WESTERN BLOTTING;

ADENYLATE CYCLASE; ANIMALS; FORSKOLIN; FRONTAL LOBE; GUANYLYL IMIDODIPHOSPHATE; IMIDAZOLES; MELATONIN; PARIETAL LOBE; RATS; RATS, WISTAR; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN;

EID: 0036828701     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-079X.2002.02906.x     Document Type: Article

References (55)

1. Bennett-Clarke C, Ramagnano Ma, Joseph Sa. Distribution of somatostatin in the rat brain: Telencephalon and diencephalon. Brain Res 1980; 188:473-486.
2. Brownstein M, Arimura A, Sato H et al. The regional distribution of somatostatin in the rat brain. Endocrinology 1975; 96:1456-1461.
3. Shiosaka S, Takachuki K, Sakanaka M et al. Ontogeny of somatostatin-containing neuron system of the rat: Immunohistochemical analysis. II. Forebrain and diencephalon. J Comp Neurol 1982; 204:211-224.
4. Johansson O, Hokfelt T. Thyrotropin releasing hormone, somatostatin and enkephalin: Distribution studies using immunohistochemical techniques. J Histochem Cytochem 1980; 28:364-366.
5. Lowe WL, Jr., Schaner AE, Roberts CT, et al. Developmental regulation of somatostatin gene expression in the brain is region specific. Mol Endocrinol 1987; 1:181-187.
6. Epelbaum J. Somatostatin in the central nervous system: Physiology and pathological modifications. Prog Neurobiol 1986; 27:63-100.
7. De los Frailes MT, Cacicedo L, Lorenzo Mj et al. Neurotransmitter regulation of somatostatin secretion by fetal rat cerebral cortical cells in culture. J Endocrinol Invest 1993: 16:661-668.
8. Hendry SHC, Jones EG. De Felipe J et al. Neuropeptide-containing neurons of the cerebral cortex are also GABAergic. Proc Natl Acad Sci USA 1984; 81:6526-6530.
9. Chronwall BM, Chase TN, O'Donohue. Coexistence of neuropeptide Y and somatostatin in rat and human cortical and rat hypothalamic neurons. Neurosci Lett 1984; 52:213-217.
10. Kowall NW. Beak MF. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: Normal anatomy and alterations in Alzheimer's disease. Ann Neurol 1988; 23:105-114.
11. Patel YC, Somatostatin and its receptor family. Front Neuroendocrinol 1999; 20:157-198.
12. Bruno JF, XU Y, Song J et al. Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Endocrinology 1993; 133:2561-2567.
13. Izquierdo-Claros RM, Boyano-Adánez MC, Torrecillas G et al. Acute modulation of somatostatin receptor function by melatonin in the rat frontoparietal cortex. J Pineal Res 2001; 31:46-56.
14. Kovacs GL, Gayari I, Telegdy G et al. Effect of melatonin and pinealectomy on avoidance and exploratory activity in the rat. Physiol Behav 1974; 13:349-355.
15. Golus P, King MG. The effects of melatonin on open field behavior. Pharmacol Biochem Behav 1981; 15:883-886.
16. Sugden D. Psychopharmacological effects of melatonin in mouse and rat. J Pharmacol Exp Ther 1983; 227:587-591.
17. Van-Wimersma-Greidamus TB, Maigret C, Krechting B. Excessive grooming induced by somatostatin or its analog SMS 201-995. Eur J Pharmacol 1987; 144:277-285.
18. Vecsei L, Bollok I, Telegdy G. Comparative studies with cyclic and linear somatostatin on active avoidance behaviour and open-field activity in rats. Acta Physiol Hung 1983; 61:43-49.
19. Wolden-Hanson T, Mitton DR, Mccants RL et al. Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology 2000; 141:487-497.
20. Huerto-Delgadillo L, Antón-Tay F, Benítez-King G. Effect of melatonin on microtubule assembly depend on hormone concentration: role of melatonin as a calmodulin antagonist. J Pineal Res 1994; 17:55-62.
21. Alexiuk NA, Vriend JP. Melatonin reduces dopamine content in the neurointermediate lobe of male syrian hamsters. Brain Res Bull 1993; 32:433-436.
22. 3H]DOPA in various regions of the brain, J Neurochem 1966; 13:655-669,
23. Lowry OH, Rosenbrough NJ, Farr AL et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275.
24. Patel YC, Reichlin S. Somatostatin in hypothalamus, extrahypotalamic brain, and peripheral tissues of the rat. Endocrinology 1978; 102:523-530.
25. 131l-labelled human growth hormone of high specific radioactivity. Biochem J 1963; 89:114-123.
26. Reubi JC, Perrin MH, Rivier JE et al. High affinity binding sites for a somatostatin-28 analog in rat brain. Life Sci 1981; 28:2191-2198.
27. Czernik AJ, Petrack V. Somatostatin receptor binding in rat cerebral cortex. Characterization using a nonreducible somatostatin analog. J Biol Chem 1983; 285:5525-5530.
28. Aguilera G, Parker DS, Catt KJ. Characterization of somatostatin receptor in the rat adrenal glomerulose zone. Endocrinology 1982; III:1376-1384.
29. Challiss RAJ, Batty I, Nahorski SR. Mass measurements of inositol(1,4.5)trisphosphate in rat cerebral cortex slices using a radioreceptor assay: Effects of neurotransmitters and depolarization. Biochem Biophys Res Commun 1988; 157:684-691.
30. Houslay MD, Metcalfe JC, Warren GB et al. The glucagob-on receptor of rat liver plasma membrane can couple to adenylate cyclase without activating it, Biochim Biophys Acta 1976; 436:489-494.
31. Gilman AG. A protein binding assay for adenosine 3′5′-cyclic monophosphate. Proc Natl Acad Sci USA 1970; 67:305-312.
32. Laemmli UK. Cleaveage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
33. Munson PJ. Rodbard D. A versatile computerized approach for characterization of ligand binding systems. Anal Biochem 1980; 107:220-239.
34. Scatchard G. The attractions of proteins for small molecules and ions. Ann NY Acad Sci 1949; 51:660-671.
35. Meyerhof W. The elucidation of somatostatin receptor functions: A current view, Rev Physiol Biochem Pharmacol 1998; 133:55-108.
36. Golombek DA, Pévet P, Cardinali DP. Melatonin effects on behavior: Possible mediation by the central GABAergic system. Neurosci Behav Rev 1996; 20:403-412.
37. Segal DS, Mandell AJ. Differential behavioral effects of hipothalamic polypeptides. In: The Thyroid Axis Drugs and Behavior. PRANGE AJ. eds, Raven Press. New York, 1974; pp 129-133.
38. Renaud PL, Martin JB, Brazeau P. Depressant action of TRH, LH-RH and somatostatin activity on central neurones. Nature 1975; 255:233-235.
39. 125l-Tyrt-somatostatin binding sites in rat brain. J Neurochem 1982; 38:1515-1523.
40. Laudon M, Nir I, Zisapel N. Melatonin receptors in discrete brain areas of the male rat. Impact for aging on density and on circadian rhythmicity. Neuroendocrinology 1988; 48:577-583.
41. Hadley ME. Endocrinology. Prentice Hall, Englewood Cliffs, NJ, 1988.
42. 125l-melatonin binding sites in the rat brain. J Basic Clin Physiol Pharmacol 1992; 3:253-268.
43. Hazlerigg DG, Gonzalez-Brito A, Lawson W et al. Prolonged exposure to melatonin leads to time dependent sensitization of adenylate cyclase and down-regulates melatonin receptors in pars tuberalis cells from ovine pituitary. Endocrinology 1993; 132:285-292.
44. 2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization. Mol Pharmacol 1991; 39:55-63.
45. Thomas JM, Homan BB. Adenylate cyclase supersensitivity: A general means of cellular adaptation to inhibitory agonists. Trends Pharmacol Sci 1987; 8:303-311.
46. Strassheim D, Palmer T, Milligan G et al. 1991; Alterations in G-protein expression and the hormonal regulation of adenylate cyclase in the adipocytes of obese (fa fa) Zucker rats. Biochem J 276:197-202.
47. Attali B, Vogel Z. Long-term opiate exposure leads to reduction of the subunit of GTP-binding proteins. J Neurochem 1989; 53:1636-1639.
48. Longabaugh JP, Didsbury J, Spiegel A et al. Modification of rat adipocite A1 adenosine receptor-adenylate cyclase system during chronic exposure to an Al adenosine receptor agonist: Alterations in the quantity of Gs alpha and Gi alpha are not associated with changes in their mRNAs. Mol Pharmacol 1989; 36:681-688.
49. Brydon L, Roka F, Petit L et al. Dual signaling of human Mella melatonin receptors via Gi2, Gi3 and Gqll proteins. Mol Endocrinol 1999; 13:2025-2038.
50. Garlind A, Fowler CJ, Alafuzo I et al. Neurotransmitter-mediated inhibition of post-morten human brain adenylyl cyclase. J Neural Transm Gen Sect 1992; 87:113-124.
51. Nagao M, Sakamoto C, Matozaki T et al. Coupling of inhibitory GTP binding protein to somatostatin receptors on rat cerebrocortical membranes. Nippon Naibunpi Gakkai Zasshi 1989; 65:1357-1366.
52. Chneiweiss H, Glowinski J, Premont J. Modulation by monoamines of somatostatin-sensitive adenylate cyclase on neuronal and glial cells from the mouse brain in primary cultures. J Neurochem 1985; 44:1825-1831.
53. Chneiweiss H, Glowinski J, Premont J. Vasoactive intestinal polypeptide receptors linked to an adenylate cyclase and their relationship with biogenic amine and somatostatin-sensitive adenylate cyclase on central neuronal and glial cells in primary cultures. J Neurochem 1985; 44:779-786.
54. Law SF, Zaina S, Sweet R et al. Giαl selectively couples somatostatin receptor subtype 3 to adenelyl cyclase: Identification of the functional domains of this α subunit necessary for mediating the inhibition by somatostatin of cAMP formation. Mol Pharmacol 1994; 45:587-590.
55. Benítez-King G, Anton-Tay F. Calmodulin mediates melatonin cytoskeletal effects. Experientia 1993; 49:635-641.